"CVS' Drug Price Revamp: Limited Impact on Consumers"

CVS Pharmacy's new drug pricing system, CVS CostVantage, aims to simplify and increase transparency in the payment structure for prescription medications. However, it is unlikely to result in lower costs or greater clarity for consumers. The new model primarily affects the arrangements between CVS Pharmacy, pharmacy benefit managers (PBMs), and payors such as insurers and employers. While the initiative may reduce the cost of most drugs, the savings will be passed along to PBMs and payors, with no mention of cost savings for consumers. Critics question whether the move will actually decrease costs or if it is merely a response to pressure from Congress and competitors.